Bladder Cancer

Inequity in selective referral to high-volume hospitals for genitourinary malignancies. April 9, 2020

Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis. April 9, 2020

The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion. April 9, 2020

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis. April 9, 2020

Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis. April 9, 2020

The clinical study of en Bloc transurethral resection with 980 nm Laser for treatment of primary non-muscle invasive bladder cancer. April 8, 2020

Quantifying the effect of biopsy lateral decubitus patient positioning compared to supine prostate MRI scanning on prostate translocation and distortion. April 8, 2020

The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database. April 8, 2020

Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability. April 8, 2020

Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. April 7, 2020

The impact of three different bladder neck reconstruction techniques on urinary continence after laparoscopic radical prostatectomy. April 7, 2020

Eosinophilic Leukemoid Reaction with Eosinophilic Tumor Tissue Infiltration as an Extermely Poor Prognostic Factor in Urinary Bladder Cancer- a Known Entity Revisited. April 7, 2020

The Distinct Molecular Profile of the Small-Cell Bladder Cancer Variant - Expert Commentary April 6, 2020

Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer. April 6, 2020

A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables. April 6, 2020

Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer. April 6, 2020

Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression. April 6, 2020

To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer. April 6, 2020

UroGen Announces Positive Interim Data from Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer April 3, 2020

PD1/PD-L1 axis in uro-oncology. April 3, 2020

Page 1 of 338